Drugging Undruggable Molecular Cancer Targets

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Cancer presents numerous molecular targets for therapy.
• Many validated cancer targets are currently undruggable using traditional methods.

Purpose of the Study:

• To reclassify "undruggable" cancer targets as "undrugged."
• To explore strategies for targeting these previously inaccessible molecules.
• To expand therapeutic options for cancer treatment.

Main Methods:

• Literature review and analysis of "undruggable" targets.
• Proposed reclassification framework for cancer targets.
• Identification and discussion of strategies for targeting undrugged molecules.

Main Results:

• Identified a significant number of validated cancer targets currently considered undruggable.
• Proposed a new classification of "undrugged" targets.
• Highlighted three major classes of undrugged targets and potential therapeutic strategies.

Conclusions:

• Reclassifying targets from "undruggable" to "undrugged" opens new avenues for drug development.
• Developing strategies to target these molecules is crucial for reducing cancer morbidity and mortality.
• Expanding the scope of pharmacologically manipulated targets is key to advancing cancer therapy.